Conversion hepatectomy for unresectable hepatocellular carcinoma: Principles of patient selection and surgical decision-making
BioScience Trends · 2026
DOI: 10.5582/bst.2026.01229 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioScience Trends, 2026. Verfasst von Jiayun Ge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
- Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Fujian Medical University Cancer Center, Fuzhou, Fujian 350122, China.
- National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Zitieren
APA
Ge, J., Yang, F., Chen, Y., Hong, H., & Tang, W. (2026). Conversion hepatectomy for unresectable hepatocellular carcinoma: Principles of patient selection and surgical decision-making. BioScience Trends. https://doi.org/10.5582/bst.2026.01229
Vancouver
Ge J, Yang F, Chen Y, Hong H, Tang W. Conversion hepatectomy for unresectable hepatocellular carcinoma: Principles of patient selection and surgical decision-making. BioScience Trends. 2026. doi:10.5582/bst.2026.01229
BibTeX
@article{Ge2026,
author = {Ge, Jiayun and Yang, Fan and Chen, Yanling and Hong, Haijie and Tang, Wei},
title = {Conversion hepatectomy for unresectable hepatocellular carcinoma: Principles of patient selection and surgical decision-making},
journal = {BioScience Trends},
year = {2026},
doi = {10.5582/bst.2026.01229}
}
EUVIMED